The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.

AIDS vaccine AIDS/HIV Virology

Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
20 Feb 2024
Historique:
medline: 20 2 2024
pubmed: 20 2 2024
entrez: 20 2 2024
Statut: aheadofprint

Résumé

Persistent controllers (PC) maintain antiretroviral-free HIV-1 control indefinitely over time while transient controllers (TC) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir of these phenotypes to identify the factors that lead to HIV progression and to open new avenues in HIV cure strategies. The characterization of HIV-1 reservoir, from peripheral blood mononuclear cells, was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-seq; MIP-seq). PC and TC before losing virological control, presented significantly lower total, intact and defective proviruses compared to participants on antiretroviral therapy (ART). No differences were found in total and defective proviruses between PC and TC. However, intact provirus levels were lower in PC compared to TC, being the intact/defective HIV-DNA ratio significantly higher in TC. Clonally expanded intact proviruses were found only in PC and located in centromeric satellite DNA or zinc-finger genes, both associated with heterochromatin features. In contrast, sampled intact proviruses were located in permissive genic euchromatic positions in TC. These results suggest the need for, and can give guidance to the design of, future research to identify a distinct proviral landscape that may be associated with the persistent control of HIV-1 without ART. Instituto de Salud Carlos III (FI17/00186, FI19/00083, MV20/00057 PI18/01532, PI19/01127 and PI22/01796), Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía (PI20/1276), Gilead Fellowships (GLD22/00147) and I+D+iFEDER Andalucía 2014-2020 (US-1380938).

Sections du résumé

BACKGROUND BACKGROUND
Persistent controllers (PC) maintain antiretroviral-free HIV-1 control indefinitely over time while transient controllers (TC) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir of these phenotypes to identify the factors that lead to HIV progression and to open new avenues in HIV cure strategies.
METHODS METHODS
The characterization of HIV-1 reservoir, from peripheral blood mononuclear cells, was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-seq; MIP-seq).
RESULTS RESULTS
PC and TC before losing virological control, presented significantly lower total, intact and defective proviruses compared to participants on antiretroviral therapy (ART). No differences were found in total and defective proviruses between PC and TC. However, intact provirus levels were lower in PC compared to TC, being the intact/defective HIV-DNA ratio significantly higher in TC. Clonally expanded intact proviruses were found only in PC and located in centromeric satellite DNA or zinc-finger genes, both associated with heterochromatin features. In contrast, sampled intact proviruses were located in permissive genic euchromatic positions in TC.
CONCLUSIONS CONCLUSIONS
These results suggest the need for, and can give guidance to the design of, future research to identify a distinct proviral landscape that may be associated with the persistent control of HIV-1 without ART.
FUNDING BACKGROUND
Instituto de Salud Carlos III (FI17/00186, FI19/00083, MV20/00057 PI18/01532, PI19/01127 and PI22/01796), Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía (PI20/1276), Gilead Fellowships (GLD22/00147) and I+D+iFEDER Andalucía 2014-2020 (US-1380938).

Identifiants

pubmed: 38376918
pii: 174215
doi: 10.1172/JCI174215
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Carmen Gasca-Capote (C)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Xiaodong Lian (X)

Ragon Institute of MGH, MIT and Harvard, Cambridge, United States of America.

Ce Gao (C)

Ragon Institute of MGH, MIT and Harvard, Cambridge, United States of America.

Isabelle C Roseto (IC)

Ragon Institute of MGH, MIT and Harvard, Cambridge, United States of America.

María Reyes Jiménez-León (MR)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Gregory Gladkov (G)

Ragon Institute of MGH, MIT and Harvard, Cambridge, United States of America.

María Inés Camacho-Sojo (MI)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Alberto Pérez-Gómez (A)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Isabel Gallego (I)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Luis E Lopez-Cortes (LE)

Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.

Sara Bachiller (S)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Joana Vitalle (J)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Mohammed Rafii-El-Idrissi Benhnia (M)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Francisco J Ostos (FJ)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Antonio R Collado-Romacho (AR)

Infectious Diseases Unit, Internal Medicine Service, Torrecardenas University Hospital, Almería, Spain.

Jesús Santos (J)

Infectious Diseases, Microbiology and Preventive Medicine Unit, Virgen de la Victoria University Hospital, Málaga, Spain.

Rosario Palacios (R)

Infectious Diseases, Microbiology and Preventive Medicine Unit, Virgen de la Victoria University Hospital, Málaga, Spain.

Cristina Gomez-Ayerbe (C)

Infectious Diseases, Microbiology and Preventive Medicine Unit, Virgen de la Victoria University Hospital, Málaga, Spain.

Leopoldo Muñoz-Medina (L)

Unit of Infectious Diseases, San Cecilio University Hospital, Biohealth Research Institute, IBS-Granada, Granada, Spain.

Andrés Ruiz-Sancho (A)

Unit of Infectious Diseases, San Cecilio University Hospital, Biohealth Research Institute, IBS-Granada, Granada, Spain.

Mario Frias (M)

CIBERINFEC, Carlos III Health Institute (ISCIII), Madrid, Spain.

Antonio Rivero-Juarez (A)

CIBERINFEC, Carlos III Health Institute (ISCIII), Madrid, Spain.

Cristina Roca-Oporto (C)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Carmen Hidalgo-Tenorio (C)

Unit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, Granada, Spain.

Anna Rull (A)

CIBERINFEC, Carlos III Health Institute (ISCIII), Madrid, Spain.

Julian Olalla (J)

Internal Medicine Departament, Costa Del Sol Hospital, Marbella, Spain.

Miguel A Lopez-Ruz (MA)

Unit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, Granada, Spain.

Francesc Vidal (F)

CIBERINFEC, Carlos III Health Institute (ISCIII), Madrid, Spain.

Consuelo Viladés (C)

CIBERINFEC, Carlos III Health Institute (ISCIII), Madrid, Spain.

Andrea Mastrangelo (A)

Division of Immunology and Allergy, Lausanne University Hospital, Lausanne, Switzerland.

Matthias Cavassini (M)

Division of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.

Nuria Espinosa (N)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, Seville, Spain.

Matthieu Perreau (M)

Division of Immunology and Allergy, Lausanne University Hospital, Lausanne, Switzerland.

Joaquin Peraire (J)

CIBERINFEC, Carlos III Health Institute (ISCIII), Madrid, Spain.

Antonio Rivero (A)

CIBERINFEC, Carlos III Health Institute (ISCIII), Madrid, Spain.

Luis F López-Cortes (LF)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Mathias Lichterfeld (M)

Ragon Institute of MGH, MIT and Harvard, Cambridge, United States of America.

Xu G Yu (XG)

Ragon Institute of MGH, MIT and Harvard, Cambridge, United States of America.

Ezequiel Ruiz-Mateos (E)

Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital,Spanish National Research Council (CSIC), University of Seville, Seville, Spain.

Classifications MeSH